Oxford Immunotec

Company

Pharmaceutics, medicine, health care
USA

Oxford Immunotec is the global diagnostic company aimed at improvement of medical care by providing the innovation tests in the field of immunology. The patented technology of the T-SPOT test measures indications of the certain cages of the immune system known as T-lymphocytes, for determination of the diagnosis, the forecast or monitoring of patients with immunological diseases.

T-lymphocytes are principal components of the immune system of the person which are involved in control and control of many infectious, oncological and autoimmune diseases. The innovative test of T-SPOT.TB company founded on the platform of T-SPOT technology is used for testing for latent tuberculosis. The T-SPOT.TB test is approved for sale in more than 50 countries, including the USA where it got approval from FDA, in Europe where received marking of CE and also in Japan and China. The main offices of the company there is near Oxford, Great Britain, and Marlborough, Massachusetts, the USA.

Источник — «https://tadviser.com/index.php/Company:Oxford_Immunotec»

The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article
If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible.

Simple Link

How to create a "smart plant": Key characteristics of a modern digital enterprise 9200

Model Studio CS: How to use BIM to give new impetus to the development of the fuel and energy complex 8200